Bacterial cell division proteins as antibiotic targets
Author
dc.contributor.author
Den Blaauwen, Tanneke
Author
dc.contributor.author
Andreu, José Manuel
es_CL
Author
dc.contributor.author
Monasterio Opazo, Octavio
es_CL
Admission date
dc.date.accessioned
2014-12-12T14:18:19Z
Available date
dc.date.available
2014-12-12T14:18:19Z
Publication date
dc.date.issued
2014
Cita de ítem
dc.identifier.citation
Bioorganic Chemistry 55 (2014) 27–38
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.bioorg.2014.03.007
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/119815
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Proteins involved in bacterial cell division often do not have a counterpart in eukaryotic cells and they are
essential for the survival of the bacteria. The genetic accessibility of many bacterial species in combination
with the Green Fluorescence Protein revolution to study localization of proteins and the availability
of crystal structures has increased our knowledge on bacterial cell division considerably in this century.
Consequently, bacterial cell division proteins are more and more recognized as potential new antibiotic
targets. An international effort to find small molecules that inhibit the cell division initiating protein FtsZ
has yielded many compounds of which some are promising as leads for preclinical use. The essential
transglycosylase activity of peptidoglycan synthases has recently become accessible to inhibitor screening.
Enzymatic assays for and structural information on essential integral membrane proteins such as
MraY and FtsW involved in lipid II (the peptidoglycan building block precursor) biosynthesis have put
these proteins on the list of potential new targets. This review summarises and discusses the results
and approaches to the development of lead compounds that inhibit bacterial cell division.
2014 Elsevier Inc. All rights
en_US
Patrocinador
dc.description.sponsorship
DIVINOCELL project of the European Commission (FP7-Health-
2007-B-223431), O.M. by FONDECYT # 1130711 and J.M.A. by
MINECO BFU2011-23416.